Symptom Information: Sort according to HPO 

1
(HPO:0002273) Tetraparesis 15 / 7739
2
(HPO:0002385) Paraparesis 12 / 7739
3
(HPO:0002423) Long-tract signs 7 / 7739
4
(HPO:0002512) Brain stem compression 2 / 7739
5
(HPO:0002644) Abnormality of pelvic girdle bone morphology 31 / 7739
6
(HPO:0002653) Bone pain 75 / 7739
7
(HPO:0002659) Increased susceptibility to fractures 110 / 7739
8
(HPO:0002797) Osteolysis 68 / 7739
9
(HPO:0002953) Vertebral compression fractures 14 / 7739
10
(HPO:0003080) Hydroxyprolinuria 7 / 7739
11
(HPO:0003084) Fractures of the long bones 5 / 7739
12
(HPO:0003155) Elevated alkaline phosphatase 52 / 7739
13
(HPO:0006824) Cranial nerve paralysis 81 / 7739
14
(HPO:0008513) Bilateral conductive hearing impairment 40% [HPO:probinson] 11 / 7739
15
(OMIM) Deafness in 30-50% of patients with skull involvement 1 / 7739
16
(OMIM) Mixed regions of osteosclerosis and osteolysis 1 / 7739
17
(OMIM) Abnormal uptake of radio-labelled bisphosphates in affected sites on bone scan 1 / 7739
18
(OMIM) Deformity or enlargement of bones 1 / 7739
19
(HPO:0002758) Osteoarthritis 78 / 7739
20
(OMIM) Most commonly affected site 1 / 7739
21
(OMIM) Percentage of bone-derived alkaline phosphatase is >60% in patients versus 40% in healthy adult subjects 1 / 7739
22
(HPO:0000006) Autosomal dominant inheritance 2518 / 7739
23
(HPO:0001425) Heterogeneous 132 / 7739